Aging means “becoming a target” of the industry, one expert said. After decades of debate, politicians of all stripes are ...

Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.

Lupin’s Global CFO, Ramesh Swaminathan, highlights the company’s strategy to boost US revenue through multiple upcoming product launches, including injectables and biosimilars.

HCB101, a novel Fc-based anti-SIRPα-CD47 fusion protein, has received orphan drug designation (ODD) from the FDA for the ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story RFK Jr. targets ultra-processed foods ...

As of February 13, 2026, shares of Eli Lilly (NYSE:LLY) were trading at $1,040, just 5.8% below the stock’s all-time high. Retail sentiment has turned decisively bullish following the company’s Q4 ...

Hims & Hers Health (NYSE:HIMS) has crashed 47.96% over the past month, falling from $31.32 on January 14 to $16.30 as of ...

Spinal cord injury remains one of the most challenging neurological conditions to treat, largely because damage continues to worsen long after the initial trauma. Secondary injury processes—driven by ...

She identified 2 primary frontiers for clinical investigation: the eradication of persistent cancer cells and the management ...

HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled upregulation of FAN1, a genetically validated target in Huntington’s disease Clinical Advisory Board formed to ...

VULNERABLE women are being forced to commit sexual acts to pay off drug debts that might not even be theirs, The Irish Sun ...

From paused mail delivery and shuttered bank branches to limited government services, Americans navigating the federal holiday will see a clear divide between public sector closures and private-sector ...